Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers.
Saved in:
| Title: | Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers. |
|---|---|
| Authors: | Cai Y; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Zhao P; VIB-KU Leuven Center for Cancer Biology, VIB, Leuven 3000, Belgium.; Department of Oncology, KU Leuven, Leuven 3000, Belgium., Wu F; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Zhao H; Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Shao H; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Marra A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Patel P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Weill Cornell Graduate School of Medical Sciences, New York, NY 10065, USA., O'Connell E; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Fink E; Department of Cancer Biology, Stritch School of Medicine, Loyola University Chicago, Chicago, IL 60153, USA., Miele MM; Proteomics Core, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Li Z; Proteomics Core, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., De Stanchina E; Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Cocco E; Department of Biochemistry and Molecular Biology/Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA., Razavi P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Toska E; Sidney Kimmel Comprehensive Cancer Center and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.; Department of Biochemistry and Molecular Biology, Johns Hopkins School of Public Health, Baltimore, MD 21205, USA., Fanning SW; Department of Cancer Biology, Stritch School of Medicine, Loyola University Chicago, Chicago, IL 60153, USA., Xu G; National Institute of Biological Sciences (NIBS), Beijing 102206, China., Sablina AA; VIB-KU Leuven Center for Cancer Biology, VIB, Leuven 3000, Belgium.; Department of Oncology, KU Leuven, Leuven 3000, Belgium., Scaltriti M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Chandarlapaty S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. |
| Source: | Science translational medicine [Sci Transl Med] 2025 Jun 04; Vol. 17 (801), pp. eadk7786. Date of Electronic Publication: 2025 Jun 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
